Anti-GRIK1/ EAA3/ EEA3 monoclonal antibody
Anti-GRIK1/ EAA3/ EEA3 antibody for FACS & in-vivo assay
Go to GRIK1/GRIK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T73495-Ab-1/ GM-Tg-hg-T73495-Ab-2 | Anti-Human GRIK1 monoclonal antibody | Human |
GM-Tg-rg-T73495-Ab-1/ GM-Tg-rg-T73495-Ab-2 | Anti-Rat GRIK1 monoclonal antibody | Rat |
GM-Tg-mg-T73495-Ab-1/ GM-Tg-mg-T73495-Ab-2 | Anti-Mouse GRIK1 monoclonal antibody | Mouse |
GM-Tg-cynog-T73495-Ab-1/ GM-Tg-cynog-T73495-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GRIK1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T73495-Ab-1/ GM-Tg-felg-T73495-Ab-2 | Anti-Feline GRIK1 monoclonal antibody | Feline |
GM-Tg-cang-T73495-Ab-1/ GM-Tg-cang-T73495-Ab-2 | Anti-Canine GRIK1 monoclonal antibody | Canine |
GM-Tg-bovg-T73495-Ab-1/ GM-Tg-bovg-T73495-Ab-2 | Anti-Bovine GRIK1 monoclonal antibody | Bovine |
GM-Tg-equg-T73495-Ab-1/ GM-Tg-equg-T73495-Ab-2 | Anti-Equine GRIK1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T73495-Ab-1/ GM-Tg-hg-T73495-Ab-2; GM-Tg-rg-T73495-Ab-1/ GM-Tg-rg-T73495-Ab-2; GM-Tg-mg-T73495-Ab-1/ GM-Tg-mg-T73495-Ab-2; GM-Tg-cynog-T73495-Ab-1/ GM-Tg-cynog-T73495-Ab-2; GM-Tg-felg-T73495-Ab-1/ GM-Tg-felg-T73495-Ab-2; GM-Tg-cang-T73495-Ab-1/ GM-Tg-cang-T73495-Ab-2; GM-Tg-bovg-T73495-Ab-1/ GM-Tg-bovg-T73495-Ab-2; GM-Tg-equg-T73495-Ab-1/ GM-Tg-equg-T73495-Ab-2 |
Products Name | Anti-GRIK1 monoclonal antibody |
Format | mab |
Target Name | GRIK1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GRIK1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species GRIK1/ EAA3/ EEA3 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-T73495 |
Target Name | GRIK1 |
Gene ID | 2897,14805,29559,705699,487719,101097165,533760,100053602 |
Gene Symbol and Synonyms | A830007B11Rik,D16Ium24,D16Ium24e,EAA3,EEA3,GLR5,GluK1,GluK5,gluR-5,GLUR5,Glurbeta1,GRIK1 |
Uniprot Accession | P39086,P22756 |
Uniprot Entry Name | GRIK1_HUMAN,GRIK1_RAT |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000171189 |
Target Classification | N/A |
The target: GRIK1, gene name: GRIK1, also named as EAA3, EEA3, GLR5, GLUR5, GluK1, gluR-5. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to alter the properties of ion flow. Alternative splicing, resulting in transcript variants encoding different isoforms, has been noted for this gene. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.